Philadelphia Jury Returns $8 Billion Verdict in Risperdal Case: In the first jury verdict in five years over the Risperdal drug, a Philadelphia jury returned an $8 billion punitive damages decision against a unit of Johnson & Jonson. (Law360)
To sign up to receive our email with updates on Legal Reform, fill in the following fields. When you hit submit, you consent to our processing of the personal data you provide us with. Thanks and welcome.